...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
...eference laboratory and a worldwide leader in inno...ffers an extensive test menu of highly complex and...hology. Owned by the University of Utah, ARUP Labo...tion's university teaching hospitals and children'...
Medicine Products:(Date:11/27/2009)...e, Nov. 27 Team Garmin-Slipstream,...cated to ethical sporting and developing the next ...hat it will become Team Garmin-Transitions with th... of the team. Transitions Optical is the world,s l...the most advanced photochromic technology in the w...
(Date:11/27/2009)...dings has announced that it has become a national ...rgest nonprofit organizations dedicated to arthrit... Delray Beach, FL (Vocus) Novembe...), a company specializing in the marketing and ret...has announced today that is has become a national ...
(Date:11/27/2009)...edical, economic burdens, study predicts , ...r of people with diabetes in the United States is ...tudy predicts. , That would bring the total by ..., up from 23.7 million today. , , At the same ti... triple, the study also warns, rising from an esti...
(Date:11/27/2009)...h™ announced today that Spectrum Health (Gra...terprise orthopedic templating solution and its Tr... (PRWEB) November 27, 2009 -- Voyant Hea...rand Rapids, Michigan) has licensed its TraumaCad ...TraumaCad Extend workflow solution, to allow its o...
(Date:11/27/2009)...anufacturers who use medical load cells at the hea...s by bringing in technology partner Flintec early ...ctive medical manufacturers are calling in Flintec...rojects, ensuring that progress will not be constr...outdated technology. , (P...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4... CHICAGO, IL, November 15, 2007, 2007/PRNewswire/...: ADLS), today announced positive results from Tri...ical trials designed to assess the safety and effe...ng cause of death in the United States. The prima...
...Eye Care Practices throughout North America to Par...etes Day~, MARLBOROUGH, Mass., Nov. 15 In recogn...cal technology company for the design,development,...00 eye care practices throughout North America wil...
... New clinical standards on the treatment of patie...ollowing an exhaustive review of all available lit...ar review of original research and systematic revi... Critical Care Medicine. , CF is a complex geneti...
...ORONA DEL MAR, Calif., Nov. 15 In 2004, Olivia,Go...ing cosmetic surgery.,More recently, Dr. Donde Wes...metic surgery. (Photo: http://www.newscom.com/cg...anesthesia risks,like those associated with genera...
...ALLOWAY, N.J., Nov. 15 Understanding people usual...days, Dr. Therese Pasqualoni,recommends her Strike...ay,to help adults monitor their daily food and bev...It Healthy(TM) Weight and Health Management System...
...OKYO, Japan and CHIPPENHAM, England, November 15, ...x: 4565) and Vectura Group plc ("Vectura"; LSE: VE...safety study of QVA149 for the treatment,of chroni...ce-daily long-acting beta-2 agonist (LABA). The r...
Other Medicine News:Health News:Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia 2Health News:Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia 3Health News:Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia 4Health News:Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia 5Health News:Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia 6Health News:Cethromycin achieves all endpoints in second pivotal Phase III Trial for treatment for pneumonia 7Health News:Free Diabetes Eye Screenings Taking Place in Recognition of World Diabetes Day 2Health News:Cystic Fibrosis foundation lays out new treatment guidelines 2Health News:Cystic Fibrosis foundation lays out new treatment guidelines 3Health News:'Donde West Death Highlights Unnecessary Risk of General Anesthesia for Cosmetic Surgery,' Asserts Dr. Friedberg 2Health News:It Only Takes Minutes a Day to Strike It Healthy for the Holidays, Expert Says 2Health News:Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD 2Health News:Sosei and Vectura Announce Start of Phase II Studies of QVA149 for the Treatment of COPD 3(Date:11/25/2009)..., MOUNTAIN VIEW, Calif., Nov. 25 ...I/III clinical data from the Company,s PROTECT-1 (... in Crohn,s disease Trial) of Traficet-EN(TM) (CCX... disease demonstrated clinical efficacy with a fav... demonstrated evidence of clinical efficacy in the...
(Date:11/24/2009)..., IRVINE, Calif., Nov. 24 /PRNewswire-FirstCall/... minimally invasive treatments for aortic disorder...tay, or discontinue all proceedings in, the patent...r 2009 by Cook, Inc. The motion was filed in the ...ana. ,, Endologix has requested that the stay r...
(Date:11/24/2009)..., SAN DIEGO, Nov. 24 A...nced today that it will present at the 21st Annual...ecember 1, 2009 at 9:00 a.m. EST (6:00 a.m. PST). ...ce Hotel. Steve Worland, Ph.D., President and Chi...erview of Anadys and its clinical development prog...
Breaking Medicine Technology:ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Endologix Files Motion to Discontinue Court Proceedings Related to Alleged Patent Infringement 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2ATS Medical Announces Second Quarter 2009 Results 53548 1ATS Medical Announces Second Quarter 2009 Results 53548 2ATS Medical Announces Second Quarter 2009 Results 53548 3ATS Medical Announces Second Quarter 2009 Results 53548 4ATS Medical Announces Second Quarter 2009 Results 53548 5ATS Medical Announces Second Quarter 2009 Results 53548 6ATS Medical Announces Second Quarter 2009 Results 53548 7ATS Medical Announces Second Quarter 2009 Results 53548 8ATS Medical Announces Second Quarter 2009 Results 53548 9ATS Medical Announces Second Quarter 2009 Results 53548 10ATS Medical Announces Second Quarter 2009 Results 53548 11Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression Free Survival in Chroni 53543 1Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression Free Survival in Chroni 53543 2Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression Free Survival in Chroni 53543 3Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression Free Survival in Chroni 53543 4Journal of Clinical Oncology Publishes TREANDA Study Demonstrating Significant Improvement in Overall Response and Progression Free Survival in Chroni 53543 5Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride 28TELINTRA 28R 29 TLK199 29 Tablets In Pa 4816 1Telik Announces Publication of Positive Phase 1 Results of a Multicenter Study of Ezatiostat Hydrochloride 28TELINTRA 28R 29 TLK199 29 Tablets In Pa 4816 2